Another hormetic response to physical activity is the induction of mitochondrial biogenesis, also called mitohormesis, which is mainly induced to enhance respiratory capacity and endurance [
17]. Thus, exercise-induced mitochondrial ROS production might have an adaptive role at different levels, including the spread of energy between different pools of mitochondria, the fusion/fission state, and the status and location of mitochondrial Ca
2+. The transient increase in ROS production resulting from fission events during exercise acts as a signaling mechanism, triggering adaptive responses in the body, orchestrating the beneficial adaptations that arise from physical activity.
2.3.1. The particular mitochondria distribution and characteristics in skeletal muscle
Skeletal muscle fibers can change from a preferentially glycolytic metabolism to oxidative metabolism upon certain types of physiological exercise, a process whose cellular mechanism needs to be better understood. In turn, the EC mechanism is connected to a network of mitochondria in skeletal muscle fiber, showing a physiological communication between contractile machinery and mitochondria, in which Ca
2+ has a relevant role. Moreover, mitochondria are mobile and plastic organelles, constantly changing shape, fusing or fissioning with each other, and parallel changing their role in cellular bioenergetics [
36].
Adult skeletal muscle presents two populations of mitochondria; one group comprises both perinuclear (PN) and perivascular (PV) mitochondria, both considered peripherally located mitochondria (PLM) or subsarcolemmal (SSM), and other one, called intermyofibrillar (IMF) mitochondria [
37]. The SSM population comprises the mitochondria located beneath the plasma membrane of the muscle fiber (and, as nuclei have a similar location in adult skeletal muscle, mitochondria closely surrounding the myonuclei), and the IMF population of mitochondria, located regularly close to the sarcoplasmic reticulum terminal cisternae and the triad, at regular intervals along every myofibril [
38,
39].
IMF mitochondria form a structural arrangement characterized by the interaction of transverse mitochondrial tubules in the sarcomere, called “mitochondrial reticulum,” which has been proposed as an energetic conductive pathway from mitochondria to the contractile apparatus [
37]. Specialized proteins plays such as an intermembrane linker formed by a single protein with two membrane interacting domains in sarcoplasmic reticulum [
40]. This physical connectivity allows the passage of calcium from the reticulum to the mitochondria to be more effective since it allows the proximity between proteins such as voltage-dependent anion channel (VDAC) and RyR2 or IP3R. It has also been described that H
2O
2 would diffuse from the mitochondrial space towards these contact domains to modulate calcium release locally [
40,
41]. It is very interesting to note that these two populations of mitochondria contribute both to the muscle fiber oxidative capacity and bioenergetics, but they do so each in a specialized way, allowing in the end to optimize ATP production precisely where is needed for contraction, i.e., near the myofibrils, producing mitochondria membrane potential propagation. In agreement with this, it has been proposed that PML support the IMF energy based on the presence of higher oxidative enzyme activity [
42].
Together with the different localization and oxidative capacity, both populations express different types of proteins and different membrane potentials. For example, SSM expresses mitochondrial calcium uniporter regulator (MICU1)[
43]. The mitochondrial calcium uniporter (MCU) is a highly selective and highly regulated calcium channel inserted in the inner mitochondrial membrane that allows calcium uptake from the cytosol to mitochondria after contraction [
42,
44]. This complex (when regulated) is basally closed and is activated upon cytoplasmic Ca
2+ increases, thus allowing the ion to enter the mitochondria. The increase in ROS production increases when the mitochondrial potential (ΔΨ) is elevated. Therefore, MICU1 expression would protect against mitochondrial H
2O
2-generated damage, as elevated MCU activity would dissipate mitochondrial potential [
20].
This idea is consistent with the evidence showing that in neurons, MCU promoted the activity of the electron transport chain and the chemical reduction of NAD+ to NADH, which would imply that electrons are not available for ROS formation [
45]. Moreover, it is important to highlight that high MCU activity, also induces a mitochondrial membrane potential dissipation, facilitating the activity of the ATP synthase [
46]. It has been observed that the lower expression of MCU generates muscle atrophy, intimately relating regulation of mitochondrial Ca
2+ to the size of the muscle fiber[
47]. The action of MCU is crucial for ATP synthesis in aerobic conditions, because Ca
2+ increase is an essential cofactor for the tricarboxylic (TCA) cycle´s enzymes such as glycerol phosphate dehydrogenase (GPDH), pyruvate dehydrogenase (PDH), isocitrate dehydrogenase (ICDH), and α-ketoglutarate dehydrogenase (α-KGDH)[
48]. Thus, Ca
2+ increase can elevate the efficiency of complexes I, III, and IV of OXPHOS. Ca
2+ -induced activation of mitochondrial sodium calcium exchanger (NCLX) results in Na
+ influx into the matrix and Na
+ interacts with phospholipids in the inner leaflet of IMM, decreases its fluidity, and slows down ubiquinol (UQH2) diffusion, increasing electron flux due to major NADH availability. In simple words, calcium potentiates the establishment of the proton gradient needed for ATP synthesis, which is used for sarco/endoplasmic reticulum Ca
2+-ATPase (SERCA) to pump back calcium from the cytosol to ER [
49].
When we talk about muscle activity is important to remember that there are different types of muscle fibers (as different types of motor units). Slow-fatigue resistance type possesses a larger number of mitochondria, having a preferential oxidative metabolism that allows them to contract for long periods of time. The fast-fatigable types have a lower mitochondria content, relying on an anaerobic glycolytic metabolism, responsible for their poor fatigue resistance. These different types of muscle fibers can change from one phenotype to another depending on external demands. One of the main actors in maintaining or changing the muscle phenotype is the pattern of stimulation coming from motor neurons. In this way, it has been shown that low frequency electrical stimulation induces the expression of genes belonging to slow type phenotype, while high frequencies lead to expression of genes typical for fast phenotypes. Among the slow phenotype transcriptional profile, we can find slow isoforms of proteins from the contractile apparatus and of factors that lead to increase mitochondrial biogenesis as well as oxidative enzymes[
50,
51]. Interestingly, Quezada et al. have also shown that low frequency electrical stimulation (that allows fibers to convert to slow phenotype fibers), can decrease the expression of the MCU complex in isolated adult fibers [
52].
Higher protein levels of MCU and MICU1 per mitochondria have been observed in fast phenotypes muscles (like
flexus digitorium longus) than those belonging to a slow phenotype muscle as the soleus. From these data we can propose a hypothesis where the decrease in mRNA of the MCU complex after low-frequency electrical stimulation of isolated fibers from a fast muscle would favor a lower protein level of the MCU and MICU1 per mitochondrion, being an early metabolic response to the phenotypic shift from fast to slow phenotype muscle fiber[
52]. Also, a gradual increase in the number of mitochondria, together with a decrease in levels of MCU complex in response to a low-frequency electrical stimulus, could allow adapting mitochondrial Ca
2+ homeostasis to finally reach that of a slow muscle. On the other hand,
Mcu gen deletion produces a decrease in Ca
2+ stimulated ATP synthesis, an impairment in TCA cycle substrate flux, and a turn toward fatty acid metabolism [
44].
These data suggest that both mitochondria calcium transients and the total volume of mitochondria are somehow conjointly modulating metabolism to provide either a fast-fatigable or a slow-fatigue resistant response.
2.3.2. Function of the heterogeneity of mitochondria within the muscle fiber
The PLM mitochondria are quite different to the IMF mitochondria[
43,
53,
54]. It has been shown that electron transport chain elements needed to establish the mitochondria membrane potential are differentially distributed among SSM and IMF; in particular, Complex IV and cytochrome C are located mostly in the SSM [
43,
54]. There are also differences in the distribution of complex V (ATP synthase), which is located mostly in the IMF mitochondria [
54]. In contrast, the importin translocase of outer membrane, TOM20 has homogeneous distribution into the cell, suggesting a specific compartmentalization of different mitochondrial proteins between mitochondria subpopulations [
43].
This evidence, together with the fact that there is a shift of mitochondria membrane potential (higher in SSM in resting conditions) towards the center of the muscle fiber upon electrical stimulation [
43] prompted us to propose that in the SSM pool, the main proton-motive force is generated through the activation of complex I-IV. In contrast, ATP is generated in complex V which is in the IMF mitochondria and this ATP production will occur only after fusion of both mitochondria populations with the consequent spreading of mitochondria membrane potential. Mitochondrial ROS production will be minimal since the proton motive force is used for ATP synthesis when the electron transport chain works at a maximum level induced by exercise.
In fact,
Mcu deletion produces a decrease in Ca
2+ stimulated ATP synthesis, an impairment in TCA cycle substrate flux, and a turn toward fatty acid metabolism [
44]. Stimuli, such as extracellular ATP or electrical stimulation, can increase the expression of MCU in isolated adult fibers [
55]. In turn, it has been shown that the MCU-dependent increase in mitochondrial ROS is necessary for optimal skeletal muscle repair after an injury through the induction of actin polymerization dependent on RhoA [
56]. It is interesting to note that, using direct measurement of superoxide by electron paramagnetic resonance; Crochemore et al. demonstrated that SSM produces more superoxide than IMF[
57].
In summary, skeletal muscle mitochondria achieve this performance by separating two important functions; the first is mitochondria membrane potential generation, through calcium-sensitive oxidative phosphorylation (which occurs mainly in the subsarcolemmal population of mitochondria) and the second function is ATP production mediated by ATP synthase, which occurs in the intermyofibrillar population of mitochondria. To achieve this amazing performance, the two populations of mitochondria are not connected at rest and have a different resting protein composition. The intermyofibrillar mitochondria is enriched in ATP synthase and has a high content of mitochondrial calcium uptake 1 (MICU1) protein, MICU1 as a key regulator of mitochondrial Ca
2+ uptake, which negatively regulates calcium entry to the mitochondrial matrix through the MCU calcium channel [
58,
59]. This protein is a Ca
2+ sensor, and its functioning doesn´t impact on ΔΨ or oxygen consumption [
18,
58]. On the other hand, the subsarcolemmal mitochondria is enriched in the electron transport chain complex proteins and, having no MICU1, can reach a high calcium content upon muscle activation (
Figure 1). The model of figure 1 shows that exercise induces mitochondrial fusion of SSM and IMF, transferring electrical properties and proteins from IMF to the mitochondrial network, decreasing the ROS generation and improving energy saving design.
2.3.3. Mitochondria dynamics is altered in skeletal muscle of aging subjects and in pathological conditions.
Mitochondria fusion events in skeletal muscle fibers are hard to evidence due to the highly restricted space in which IMF mitochondria are located; fusion events nevertheless take place, and they were shown for the first time by Eisner et al. in 2014[
60].
When we consider the above-described model, it is reasonable to assume that mitochondria dynamics (fission and fusion) play an essential role in skeletal muscle function and wellbeing. Maintaining optimal skeletal muscle health requires dynamic mitochondrial function, which becomes disrupted in aging and various pathological conditions. Age-related mitochondrial dysfunction is characterized by impaired fusion/fission processes and mitophagy, leading to sarcopenia and reduced exercise capacity. In addition, diseases such as muscular dystrophies, mitochondrial myopathies, and type 2 diabetes exhibit mitochondrial fusion and fission imbalances, contributing to impaired ETC coupling.
Alterations in mitochondria dynamics have been shown to occur in middle age and more advanced age in mice[
61] and they parallel dramatic decreases in muscle function. This was evidenced by changes in the mitochondria orientation as seen by confocal microscopy, changes in both mitochondria size and shape as seen by electron microscopy and by changes in expression of proteins involved in the fission and fusion processes. Furthermore, mitochondria dynamics appears to be altered in skeletal muscle of a mouse model of alcohol consumption[
60]. Oxidative stress and reduced antioxidants reinforce mitochondrial fragmentation, suppress fusion/fission, and impair the electron transport chain, decrease ATP production, and cause DNA damage. Mitochondrial dynamics depend on proteins such as dynamis mitofusin (MFN) 1 and 2, and atrophy protein 1(OPA1) for fusion of the outer and inner mitochondrial membranes. Mitochondrial fission involves the recruitment of cytoplasmic Drp1 to the mitochondrial outer membrane, forming a ring-like structure with adaptors Mff, MiD49, and MiD51. These protein interactions ensure a balance between fusion and fission, crucial for maintaining mitochondrial dynamics and cellular functions[
62]. Deletion of OPA1 leads to mitochondrial dysfunction, reduced myogenic stem cells, decreased protein synthesis, and activation of protein breakdown.
Opa1 deletion in skeletal muscle affects the entire body, causing a premature aging phenotype that ultimately leads to animal death[
63].
Opa1 deficiency in myopathy engages TLR9, activating NF-κB and triggering muscle inflammation. This localized inflammation can become systemic, impacting the entire body. Altered growth hormone/IGF1 axis and enhanced FGF21 expression are observed, contributing to impaired growth.
Opa1 deficiency disrupts growth-related processes and promotes inflammation through inflammatory pathway activation. These processes collectively contribute to the development and progression of myopathy[
64]. Aging is associated with sarcopenia, and when an obesity condition is associated, the term sarcopenic obesity (SO) is applied. Dysfunctional adipose tissue, fatty acid excess inside the bloodstream, and low-grade systemic inflammation are combined, resulting in lipotoxicity, oxidative stress, insulin resistance, and inflammation in the skeletal muscle [
59]. It has been reported that high fat diet feeding suppresses mitochondrial biogenesis in the skeletal muscle of Zebrafish [
60], and decreases the number of SSM mitochondrial content, Mfn2, and Opa1. On the contrary, Fis1 and Drp1, both fission proteins, were found increased compared to non-obese conditions in mice [
61]. On the other hand, mitochondrial uncoupling attenuates SO by enhancing skeletal muscle mitophagy, reducing muscle inflammation, promoting mitochondrial turnover via STAT3 signaling, and mitigating muscle degradation [
62].
Figure 2.
Altered dynamics and fusion capacity between mitochondria in disease.
Figure 2.
Altered dynamics and fusion capacity between mitochondria in disease.
A common factor in many pathological conditions affecting skeletal muscle is an imbalance in mitochondrial dynamics. This imbalance is both cause and consequence of inflammation, increased ROS production, and cell death, leading to muscle deterioration characterized by dysfunctional mitochondria.
Exercise enhances the healthy mitochondrial network, promoting fusion/fission markers and biogenesis. Sarcopenia diminishes mitochondrial dynamics, mitophagy markers, and network efficiency, while exercise stimulates mitochondrial biogenesis through PGC1-α activation. Also, PGC-1α overexpression mitigates age-related increases in mitophagy markers, including Fis-1 and Drp-1 proteins, improves mitochondrial function, and reduces oxidative damage in mouse muscle[
65]. Moderate-intensity exercise can be a non-invasive treatment, activating pathways that regulate the mitochondrial network in skeletal muscle[
66]. Reduced MICU3 expression during aging leads to decreased mitochondrial Ca
2+ uptake. Studies in aged mice and senescent C2C12 cells revealed that MICU3 downregulation is associated with decreased myogenesis, increased ROS, and apoptosis. Restoring MICU3 levels increase antioxidant defenses and promotes myogenesis. These findings highlight that MICU3 is a contributing factor to ROS production and apoptotic process during aging [
67]. In the same line, mitochondrial dynamics and ROS production play crucial roles in the pathogenesis of Duchenne muscular dystrophy (DMD), a genetic skeletal muscle disorder characterized by mutations in the DMD gene that encodes dystrophin. Studies have shown that DMD patients present disruptions in mitochondrial fusion and fission processes leading to mitochondrial dysfunction and generating fragmented and dysfunctional mitochondria in muscle fibers. Intracellular Ca
2+ disruption also has been reported derived of both increased Ca
2+ influx and altered calcium release, leading to abnormally elevated resting cytosolic Ca
2+ concentration [
68]. Consequently, these effects contribute to apoptosis of the muscle cells. These abnormalities increase ROS production, oxidative stress, compromised energy production, and impaired cellular signaling, exacerbating muscle weakness and degeneration in DMD. Recent studies have highlighted the involvement of ferroptosis, a form of regulated cell death involving iron-dependent lipid peroxidation, in DMD pathology[
69,
70]. Dysregulation of NRF
2 in DMD may promote ferroptosis in muscle cells by contributing to increased susceptibility to cell death. In turn, this can exacerbate muscle degeneration and inflammation observed in DMD.
Some studies have reported cases of statin-induced muscle-related side effects, including myopathy or rhabdomyolysis; atorvastatin dose-dependently inhibits C2C12 cell viability, resulting in increased intracellular iron ions, ROS, and lipid peroxidation. These effects primarily occur in mitochondria, leading to mitochondrial dysfunction. Biomarkers of myocardial injury are elevated during atorvastatin treatment, but ferroptosis inhibitors can counteract these effects [
71]. Mechanistically, GSH depletion, along with the decrease in Nrf2, GPx4, and xCT cystine-glutamate antiporter, contribute to atorvastatin-induced muscular cell ferroptosis and damage[
71]. Moreover, an increase in iron overload, senescence, and muscle atrophy markers was found in old Senescence-accelerated mouse-prone 8 (SAMP8), a sarcopenia-like phenotype, suggesting that iron overload-induced ferroptosis plays an essential role in sarcopenia[
72].